Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Travere Therapeutics, Inc (TVTX)  
$6.16 0.18 (2.84%) as of 4:30 Fri 5/24


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 87,619,000
Market Cap: 539.73(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $5.26 - $19.34
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  993
Guru Rank Value     : 0
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Travere Therapeutics is a biopharmaceutical company focused on identifying, developing and delivering therapies to people living with kidney, liver, and metabolic diseases. Co.'s approved products include: Thiola and Thiola EC (tiopronin), which are approved for the treatment of cystinuria, a genetic cystine transport disorder that causes high cystine levels in the urine and the formation of recurring kidney stones; and Cholbam (cholic acid capsules), which is approved for the treatment for pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects, and for adjunctive treatment of patients with peroxisome biogenesis disorder-Zellweger spectrum disorder.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 54 59,539 71,172 110,112
Total Sell Value $364 $522,023 $673,181 $1,525,239
Total People Sold 1 7 7 7
Total Sell Transactions 1 16 21 43
End Date 2024-02-25 2023-11-24 2023-05-26 2022-05-26

   
Records found: 515
  Page 18 of 21  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Aselage Steve Chief Executive Officer   •       •      –    2015-09-11 4 GD $0.00 $0 D/D 3,000 368,756     -
   Shih Alvin EVP of Research & Development   •       –      –    2015-06-26 4 AS $32.70 $912,850 D/D (27,916) 202,084     -
   Lyons Gary A Director   –       •      –    2015-06-08 4 A $0.00 $0 D/D 2,000 22,000     -
   Meckler Jeffrey A Director   –       •      –    2015-06-08 4 A $0.00 $0 D/D 2,000 37,000     -
   Golding Cornelius E Director   –       •      –    2015-06-08 4 A $0.00 $0 D/D 2,000 27,000     -
   Kozarich John W Director   –       •      –    2015-04-01 4 A $0.00 $0 D/D 20,000 20,000     -
   Coughlin Timothy P Director   –       •      –    2015-03-31 4 A $0.00 $0 D/D 20,000 20,000     -
   Kotler Kevin 10% Owner   –       –       •   2015-01-13 3 IO $0.00 $0 D/D 0 2,658,854     -
   Plotkin Horacio Chief Medical Officer   •       –      –    2014-12-12 4 S $10.07 $21,146 D/D (2,100) 91,767     -
   Meckler Jeffrey A Director   –       •      –    2014-11-25 4 B $8.60 $129,050 D/D 15,000 35,000 2.39     -
   Richardson Steven Gary Director   –       •      –    2014-11-21 4 B $8.38 $51,118 D/D 6,100 129,165 2.39     -
   Shkreli Martin Fmr Officer Dir 10% Sharehldr   –       –      –    2014-11-21 4 S $8.41 $2,126,443 D/D (252,847) 1,765,168     -
   Aselage Steve Chief Executive Officer   •       •      –    2014-11-21 4 B $8.50 $73,950 D/D 8,700 371,756 2.81     -
   Shkreli Martin Fmr Officer Dir 10% Sharehldr   –       –      –    2014-11-20 4 S $8.23 $1,105,989 D/D (134,354) 2,018,015     -
   Aselage Steve Chief Executive Officer   •       •      –    2014-11-20 4 B $8.20 $10,660 D/D 1,300 363,056 2.81     -
   Shkreli Martin Fmr Officer Dir 10% Sharehldr   –       –      –    2014-11-19 4 S $8.54 $2,817,093 D/D (329,824) 2,152,369     -
   Golding Cornelius E Director   –       •      –    2014-11-19 4 B $9.00 $18,000 D/D 2,000 25,000 2.39     -
   Shkreli Martin Fmr Officer Dir 10% Sharehldr   –       –      –    2014-11-18 4 S $9.19 $2,343,501 D/D (254,975) 2,482,193     -
   Shkreli Martin Fmr Officer Dir 10% Sharehldr   –       –      –    2014-11-17 4 S $9.41 $941,100 D/D (100,000) 2,737,168     -
   Plotkin Horacio Chief Medical Officer   •       –      –    2014-11-17 4 AS $9.43 $78,594 D/D (8,333) 93,867     -
   Valeur Jensen Margaret E General Counsel   •       –      –    2014-11-17 4 A $0.00 $0 D/D 100,000 100,000     -
   Shkreli Martin Fmr Officer Dir 10% Sharehldr   –       –      –    2014-11-14 4 S $10.23 $1,022,790 D/D (100,000) 2,837,168     -
   Richardson Steven Gary Director   –       •      –    2014-11-06 4 A $0.00 $0 D/D 20,000 122,065     -
   Aselage Steve Chief Executive Officer   •       •      –    2014-11-06 4 A $0.00 $0 D/D 100,000 361,756     -
   Golding Cornelius E Director   –       •      –    2014-11-06 4 A $0.00 $0 D/D 20,000 23,000     -
  515 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 18 of 21
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us